Turning Muscles Into Motors

Rewiring Organs

Researchers at MIT are reviving paralyzed organs by means of a living implant that uses rewired nerves. This represents a new step in medicine, in which the patient’s own tissue becomes the hardware.

Numerous conditions cause nerve damage that result in organs no longer being able to function normally, or at all. Spinal cord injuries, for example, can render the bladder nonfunctional. Crohn’s disease can stop intestines from moving food along. Certain procedures can save lives but sometimes result in nerve damage that affects various bodily functions.

There may be hope on the horizon.

In a study published in Nature Communications, researchers from MIT introduced a novel myoneural actuator (MNA), that can restore movement in static organs. The MNA, when implanted, reprograms living muscles into fatigue resistant computer-controlled motors.

Not only does the system have the potential to restore function, but, according to the research team, it may be able to do so in a way that is safer and simpler than existing technology.

Addressing Previous Challenges

The MIT study confronts several challenges that previous researchers have struggled with when trying to restore function to paralyzed organs.

Some studies have focused on creating muscle tissue in the laboratory, cell by cell. But the process is extremely time consuming, and the technology is nowhere near ready for use in humans.

Some other previous efforts have tried to insert miniaturized actuators into the body. But those actuators themselves present an array of problems. They’re difficult to miniaturize, for example. Once implanted, they’re not very efficient, and they fatigue quickly. It’s very challenging to design a fatigue resistant technology that communicates with the nervous system.

A Novel Approach

The researchers at MIT have built an interface that leverages natural pathways used by the nervous system. According to Hugh Herr, the senior author of the study and a professor of media arts and sciences at the MIT Media Lab, their system enables the transmission of sensory feedback to the brain while leveraging those pathways so that the organs can be seamlessly controlled.

The MIT study focused on repurposing existing muscle within the body. The result is a living implant that uses rewired sensory nerves to revive the static organs. Researchers believe that this may represent a new genre of medicine, using the patient’s own tissue as hardware.

Says researcher Hyungeun Song, “We engineered existing muscles to become an actuator, or motor, that reinstates motion in organs.”

One of the challenges in the study was creating an actuator that would interface with the nervous system, allowing it to work properly, but also could not be overridden by the brain.

Says researcher Guillermo Herrera-Arcos, “You don’t want the brain to consciously control the muscle actuator because you want the actuator to automatically control an organ, like the heart.”

Using a computer controlled muscle to move the organ could not only ensure the organ functioned automatically, but would also bypass damaged brain pathways.

The study rerouted motor signals through sensory fibers, in order to make a computer, rather than the brain, the muscle’s new “command center.”

The scientists weren’t sure, at the beginning of the study, if it would be possible to fluidly fuse sensory nerves with muscle, a necessary step in their plan. However, when the researchers replaced motor nerves with sensory nerves in rodent muscle, the sensory nerves re-innervated the muscles and formed functional synapses.

Says Herrera-Arcos, “It’s a tremendous discovery.”

Beyond Fatigue Resistance

In addition to enabling the use of a digital controller, the sensory neurons also helped the muscles to become more resistant to fatigue. In fact, the rodent muscle in the study was 260 percent more fatigue resistant than the native muscles.

According to the researchers, this came down to the size of the axons. Motor neuron axons come in a variety of sizes. When a motor nerve is electrically stimulated, the largest ones fire first, which results in quick fatigue and exhaustion. Sensory axons, on the other hand, are more uniform in size, so the signal is broadcast more evenly across the muscle fibers, which helps the muscle to resist fatigue.

The new system developed by the researchers is a biohybrid motor called a myoneural actuator. And the results are promising.

Researchers wrapped the actuator around a paralyzed intestine in a rodent, and found that the actuator reinstated the organ’s squeezing motion. In another experiment designed to mimic residual muscle in human lower limb amputations, researchers successfully controlled rodent calf muscles using their system.

The MNA system also transmitted sensory signals to the brain. According to researcher Song, this result suggests that the team’s novel technology could be used to seamlessly link organs to the brain.

Song says, “We might be able to make a paralyzed stomach relay hunger.”

Next Steps

There are, of course, many steps between the team’s breakthrough and bringing the MNA to clinic.The system will have to undergo trials with larger animal models, and then human trials.

But if successful, the system could provide a safer route toward reviving static organs. For one thing, implanting the MNA could be done through a surgery that is already routine. The researchers believe that their system might also be both simpler and safer than existing mechanical devices or organ transplants, as they will be using the body’s own tissue rather than implanting a foreign object.

Researcher Herrera-Arcos says, “Today’s solutions are mostly synthetic: pacemakers and other mechanical assist devices. A living muscle actuator implanted alongside a weakened organ would be part of the body itself. That is a category of medicine different from anything seen in clinic.”

Researcher Song sees a multitude of possible uses for the technology, including restoring tactile feedback to people with skin grafts or who use prostheses. Song also sees the possibility for using MNA systems to improve virtual reality systems.

“The idea is that, if we couple the MNA system to skin and muscles, a person could feel what their virtual avatar is touching even though their real body isn’t moving.”

Researcher Herrera-Arcos adds, “Our research is on the brink of giving new life to various parts and extensions of the body. It’s exciting to think that our system could enhance human potential in ways that once only belonged to the realm of science fiction.”

Metastatic Model

Modeling How Cancer Spreads

A New Model Is Helping to Demystify Metastasis
When it comes to treating cancer, early detection is key. But two-thirds of cancer deaths are caused not by the original tumor, but rather by metastasis. Unfortunately, although we know the basics–that cells break away from the original tumor, travel through the blood or lymphatic fluid, and establish new tumors elsewhere in the body–many aspects of the process are still a mystery. As a result, the drugs that have been developed for the purpose of preventing or stopping the process have met with limited success.

MMI's New Microsurgery System

Beyond Human Precision

“When you think about surgery that’s small, the limitations of the human body are pretty real,” says Mark Toland, CEO of Medical Microinstruments. Microsurgery, that is, operations on structures so small that the procedure must be performed under a microscope, requires the steadiest touch. Tremors and accidental movements can have grave consequences. This is one field that seems tailor made for surgical robots.

Heart Rhythm 2026

Our favorites from HR26

On April 23-26 the 47th Heart Rhythm conference took place in Chicago. The annual event showcases the latest developments in heart arrhythmia research and treatment, and this year did not disappoint. The 2026 event received more abstracts than any previous event, reflecting the rapidly developing science in the field. More than ten thousand medical personnel came together to experience some 2,000 sessions, posters, roundtables, and hands-on experiences, including a four hour deep dive into the topic of arrhythmias in athletes.

Immunotherapy Booster Device

Supercharging the Body’s Defense System

Immunotherapy has provided a powerful array of tools for fighting a variety of diseases using the body’s own immune system. The first documented immunotherapeutic techniques date back some 3,000 years, with significant leaps forward in the late nineteenth century, the mid-twentieth century, then again in 2018, when James P. Allison and Tasuko Honjo won the Nobel Prize in Physiology or Medicine for their discovery of treating cancer by inhibition of negative immune regulation.

Pocket Sized AI Brain

A Smaller, More Efficient AI “Brain”

One of the main problems with current artificial intelligence systems is efficiency. While the human brain can do a lot with a very small amount of energy, AI systems require huge amounts of both energy and water, while producing large amounts of both pollution and greenhouse gas emissions. But a study published in Nature suggests a more efficient, and more lifelike AI brain model may be just around the corner.

Ingestible Electronics

Ingestible Electronics

The first “digital pills” were invented in 1957. They used radio frequencies to transmit pressure and temperature readings from inside the stomach. These early devices were for proof of concept only, and never went into common use. Though the test was successful, the next major step for ingestible electronics wouldn’t come until 60 years later, when the FDA approved Aripiprazole (Abilify), which is used to treat schizophrenia. The pills contain a sensor activated by acid in the stomach. A patch worn on the rib cage picks up the sensor’s signal and transmits it to a smartphone app, allowing patients to record their medication compliance and share that information with their doctors and caregivers.

CES 2026

CES 2026
From smart toilet tech to a security device that uses the vein patterns in the hand to create a one-time cryptographic key, it’s not surprising that some of the most interesting and innovative tech introduced at CES 2026 was from the Health and Wellness category. Here are the highlights.

EU Artificial Intelligence Act 2024/1689 and the Medical Device Industry

Aligning AI Innovation with EU Regulation

Artificial intelligence is revolutionising healthcare, from image analysis to design. For manufacturers competing in the global market, the main challenges for any device are building the technology itself, and the approvals process. In the European Union, this has meant making sure devices were MDR (medical device regulations) compliant. The EU Artificial Intelligence Act 2024/1689 adds an additional layer of regulation. While the MDR addresses clinical safety and effectiveness, the purpose of the AI Act is to allow the development of trustworthy AI while simultaneously ensuring the health, safety, and fundamental rights of people across the European Union.

Cancer-Seeking Proteins

An Anti-Cancer “GPS” System

The development of custom proteins for therapeutic use has just taken a giant step forward.

In 2024, half of the Nobel Prize in Chemistry went to Google DeepMind researchers John Jumper and Demis Hassabis, for their creation of AlphaFold. AlphaFold, an AI program, successfully predicted a protein’s shape and function from its chemical sequence.The other half of the prize went to David Baker of the University of Washington for solving the opposite problem: starting with the desired function of a protein, and deriving the amino acid sequence that would fold up into a molecule capable of performing that function.

Bacterial Maze

Engineering Surface Patterns to Combat Infection

In a time when bacterial resistance to current antibiotics is rising, medical science needs all the new tools it can fit into its infection-fighting toolbox. In addition to new antimicrobial drugs, and repurposing older drugs to fight bacteria, new technologies are under development that may be able to stop infection without any drugs whatsoever.

Researchers at the University of Nottingham have come up with a way to halt, and even prevent infections on plastic medical devices, which relies on alterations to the surface of the plastic itself. Their research could not only help to prevent infection through medical devices, but could also lead to technologies that help the body to eliminate bacteria before infections take hold.

Sonification

Perceptualized Date

“Humans possess more than one sense,” says Lutz Bornmann of the Max Planck Society in Germany, in his article The Sound of Science, “and there is no biological reason not to use the other ones.” When he puts it that way, it sounds quite reasonable. Much of western culture is geared toward visual representation of data–in images and text–but humans also have a highly evolved and very sophisticated system of auditory processing. Could we not also represent data through sound? 

Soft Auditory Brainstem Implant

Next-Generation Hearing Technology

Cochlear implants have been life-changing for many people with severe hearing loss. But cochlear implants have a number of limitations, and they don’t work for all types of hearing loss, for example when the cochlear nerve isn’t functional, as can be the case for patients with Neurofibromatosis type 2, cochlear ossification, certain types of head trauma, and other conditions. Auditory brainstem implants could offer an alternative to people for whom cochlear implants aren’t an option. 

3D Bioprinting

Printing Tissue

Scientists at the Feinberg Lab at Carnegie Mellon University have created the first collagen-based microphysiologic system using FRESH 3D bioprinting. 

Traditional human tissue models, such as organ-on-chip devices, are restricted by available manufacturing techniques. They are made from silicone rubber, plastics, or other synthetic materials. As a result, they’re unable to fully replicate natural tissue environments, so their effectiveness is limited.

New FDA Guidance Third Party Review Program

FDA Issues 3p510K Guidance

On November 21, 2024, the US Food and Drug Administration (FDA) published its final guidance for manufacturers seeking to authorize low-to-medium risk devices through the Third Party 510K (3P510K) Review Program. The program uses qualified third parties to conduct initial reviews of 510K device submissions. The FDA’s guidance also describes the use of third party review organizations for Emergency Use Authorization (EUA) requests.

Development in Assistive Technologies

Assistive Tech’s Rapid Growth

Between 2024 and 2025, the market value for assistive technologies grew from $2.9 billion to $4.97 billion. This figure is projected to grow to $30.9 billion by 2033. The growth is being driven by an aging population, increasing numbers of disabilities, and technological development. The United States leads the growth in demand, comprising 35 percent of the market, and of this, mobility devices–wheelchairs and walking aids–make up 40 percent. But in addition to mobility assistance, there are some exciting new advancements in products addressing other needs, including sensory assistance–hearing, sight, and even touch–exoskeletons, neural network grafts, and more.

The Rubin Observatory

Unveiling Secrets of the Universe

The Vera Rubin Observatory is set to begin its first mission: to scan the skies for cosmic events and objects. Its enormous camera will enable scientists to investigate cosmic phenomena on a scale–and at a resolution–previously unseen. Three particular phenomena of interest to the Observatory will be dark matter, dark energy, and Type Ia supernovae. For the next ten years, the Observatory will perform regular scans of the skies, looking for these and other objects and events. The Rubin Observatory plans to begin its survey, the Legacy Survey of Space and Time, in late 2025, and will release its first data set 12 to 14 months later.